Artificial intelligence (AI) is increasingly transforming healthcare in China, reshaping hospital operations, diagnostics, treatment planning, and patient management. By leveraging advanced algorithms, big data analytics, and machine learning models, hospitals are improving efficiency, enhancing clinical accuracy, and delivering more personalized care. This integration
Mandi’s IPO plan arrives at a time when Hong Kong’s capital markets are experiencing a remarkable revival. According to data from the London Stock Exchange Group, equity capital activity in the city has reached around seventy three billion dollars so far this year,
China’s rapid rise in clinical research is reshaping the global pharmaceutical landscape. With its current clinical trial capacity now comparable to that of the United States, the country is increasingly viewed as a prime destination for cutting edge drug development, international collaboration and
A fossil find with global significance A newly identified fossil from China is reshaping scientists’ understanding of how large animals moved across the ancient Earth more than 250 million years ago. The remains belong to a previously unknown species of dicynodont, a group
A milestone moment for AI driven drug development China’s biotech sector has reached a landmark moment as Hangzhou based start-up MindRank advanced its weight loss drug into Phase 3 clinical trials. The development marks the first time a Category 1 new drug in
Longevity is about daily choices not miracles When people think about living longer, they often imagine breakthroughs in medicine or expensive treatments reserved for the few. According to longevity experts, the reality is far less dramatic and far more practical. A long and
Gina Jiang has carved out a remarkable path in the world of biotechnology, emerging as one of Hong Kong’s leading figures in the development of advanced cancer therapies. Her journey has been anything but conventional. Born to an orthopaedic surgeon father and an
A new report from a US congressional commission has issued an urgent alert about China’s accelerating rise in the biotechnology field, calling the speed and scale of its progress “sobering, even frightening”. The National Security Commission on Emerging Biotechnology (NSCEB), which spent two
Suzhou, a city long celebrated for its classical gardens, ancient canals and poetic landscapes, is rapidly reinventing itself as one of China’s most ambitious biotechnology hubs. Five years ago, local leaders laid out a daring plan: transform Suzhou into the “Pharma Valley of
China’s biotechnology sector is entering a new phase of scientific acceleration as research laboratories expand their use of automated platforms for drug discovery. These systems combine robotics, artificial intelligence, high-throughput screening, and advanced data analysis tools to reduce the time required to identify
